Moreover, the expression of IQGAP3 was positively correlated with infiltration of B cells, macrophages, and dendritic cells, indicating its potential role as a tumor-specific antigen and therapeutic target in PRAD [113]. The gene discussed is IQGAP3; the disease is prostate adenocarcinoma.